Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19.
Journal
Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
28
06
2021
accepted:
10
09
2021
pubmed:
8
10
2021
medline:
15
12
2021
entrez:
7
10
2021
Statut:
ppublish
Résumé
To identify preinfection risk factors for adverse outcomes among veterans with diabetes and coronavirus disease 2019 (COVID-19) infection. We identified all Veterans Health Administration patients with diabetes and one or more positive nasal swab(s) for severe acute respiratory syndrome coronavirus 2 (1 March 2020-10 March 2021) ( Compared with HbA Among veterans with diabetes and COVID-19, higher HbA
Identifiants
pubmed: 34615690
pii: dc21-1351
doi: 10.2337/dc21-1351
pmc: PMC8669528
doi:
Substances chimiques
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2708-2713Informations de copyright
© 2021 by the American Diabetes Association.
Références
Crit Care Med. 2021 Feb 1;49(2):209-214
pubmed: 33105150
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31
pubmed: 31862745
BMJ Open Diabetes Res Care. 2021 Jun;9(1):
pubmed: 34083248
Diabetes Care. 2021 Jul;44(7):1564-1572
pubmed: 34135013
Lancet Diabetes Endocrinol. 2021 May;9(5):293-303
pubmed: 33798464
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792
pubmed: 32687793
SN Compr Clin Med. 2020;2(9):1296-1298
pubmed: 32838195
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833
pubmed: 32798471